Faculty

Institution

Unit

Venue

Theresa Werner

University of Utah

Affiliations

School of Medicine

Department of Internal Medicine

Department of Obstetrics and Gynecology

Division of Gynecologic Oncology

Department of Internal Medicine

Division of Oncology

NoneTheresa Werner is currently serving as a Internal Medicine faculty at University of Utah.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Theresa Werner

University of Utah

You can click a keyword to filter the displayed items

oncology cancer research gynecologic oncology cancer treatment gynecology pharmacology radiation oncology medicine ovarian cancer cancer care medicinal research cancer biology clinical research tumor biology gynecologic cancers cancer management pharmacotherapy enzyme inhibition therapeutic targets breast cancer surgical oncology advanced solid tumors cancer discovery molecular cancer tumor targeting cancer imaging obstetrics and gynaecology cancer genetics anti-cancer agents pharmacokinetics cancer growth radiation therapy cancer genomics endometrial cancer oncogenes cancer risk therapeutic efficacy solid tumors thoracic oncology alternative medicine complementary medicine leukemia gastrointestinal oncology breast oncology novel therapies drug safety liver cancer prospective cohort studies cohort studies radiation biology drug targeting endometrial cancers recurrent endometrial cancer vascular biology clinical guidance colorectal cancer fibroblast growth factors cancer prevention immune checkpoint inhibitors medical genetics disease progression biliary cancer treatment options field trial tumoral pathology resistant cancer phenotypes copper gluconate cancer patients bevacizumab versus chemotherapy-free study maintenance therapy first-line chemotherapy clinical practice guidelines bevacizumab versus niraparib superiority trial taxane-based chemotherapy gynecologic malignancies gynecological surgery cervical cancer reproductive health pathology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Durable Response to Braf Inhibitor Monotherapy in Recurrent Metastatic Low Grade Serous Ovarian Cancer. Gynecologic Oncology Reports (2024)

Shashank SamaSterling RosqvistTalicia SavageLesley LomoKiera SibbaldAlli StraubharTheresa L. Werner

gynecologymetastasisgynecologic cancersoncologycancer researchdurable responseovarian cancercancer treatmentinhibitor monotherapygynecologic oncology

Nccn Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024. Journal of the National Comprehensive Cancer Network (2024)

Joyce LiuAndrew BerchuckFloor J. BackesJoshua CohenRachel GrishamCharles A. LeathLainie MartinDaniela MateiDavid S. MillerSharon RobertsonLisa BarroilhetShitanshu UppalAndrea Wahner HendricksonDavid M. GershensonHeidi J. GrayArdeshir HakamAngela JainGottfried E. KonecnyJohn MoroneyElena RatnerJohn SchorgePremal H. ThakerTheresa L. WernerEmese ZsirosKian BehbakhtLee-May ChenMarie DeRosaEric L. EisenhauerGary LeiserowitzBabak LitkouhiMichael McHaleSanja Percac-LimaKerry RodabaughRoberto VargasFrankie JonesEmily KovachLisa HangSwathi RamakrishnanRonald D. AlvarezDeborah K. Armstrong

molecular gastroenterologyurologylung cancercolorectal cancermolecular cancerovarian cancerleukemiagenitourinary cancersoncogenesperineural invasionsystems biologyimmunologyvascular biologycancer registrationgliomasprostate cancercancer literacycarcinogenesis

Phase 1/2A Study of Rivoceranib, a Selective Vegfr-2 Angiogenesis Inhibitor, in Patients With Advanced Solid Tumors. Cancer Research and Treatment (2024)

Yoon-Koo KangMin-Hee RyuYong Sang HongChang-Min ChoiTae Won KimBaek-Yeol RyooJeong Eun KimJohn R WeisRachel KingsfordCheol Hee ParkSeong JangArlo McGinnTheresa L WernerSunil Sharma

cancer researchangiogenesispharmacologycancer treatmentclinical researchadvanced solid tumors

Sitravatinib in Patients With Solid Tumors Selected by Molecular Alterations: Results From a Phase Ib Study. Future Oncology (2024)

Lyudmila BazhenovaDong-Wan KimByoung Chul ChoSanjay GoelRebecca HeistTheresa L WernerKeith D EatonJudy S WangShubham PantDouglas R AdkinsCollin M BlakelyXiaohong YanSaskia NeuteboomJames G ChristensenRichard ChaoTodd Bauer

cancer biologypharmacologytherapeutic targetsphase ib studytumor biologycancer researchoncologyoncogenic agentsystems biologycancer treatmentcancer discoverytumor microenvironmentmolecular cancermolecular alterationstumor targetingmedicinal researchtumor heterogeneitysolid tumorscancer cellsoncogenesmolecular biology

Abstract Ct018: Safety and Efficacy of Three Parp Inhibitors (Parpi) Combined With the Ataxia Telangiectasia- and Rad3-Related Kinase Inhibitor (Atri) Camonsertib in Patients (Pts) With Solid Tumors Harboring Dna Damage Response (Ddr) Alterations. Cancer Research (2023)

Timothy A. YapSiddhartha YadavBenjamin HerzbergBenedito A. CarneiroElisa FontanaMartin HøjgaardMichael J. PishvaianRuth PlummerTheresa L. WernerVaibhav SahaiStephanie LheureuxElizabeth K. LeeNiharika B. MettuGregory M. CoteJoseph D. SchonhoftVictoria RimkunasIan M. SilvermanMarisa WainszelbaumGerson PeltzAdrian J. FretlandKezhen FeiDanielle UlanetInsil KimMaria KoehlerEzra RosenMichael Cecchini

medicinecancer biologyparp inhibitorspharmacologytherapeutic targetspathway analysisoncologycancer researchcancer carecancer treatmentcancer discoveryanti-cancer agentsradiation oncologymolecular cancermedicinal researchsolid tumorscancer managementprostate cancerenzyme inhibitionclinical research

Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative Medicine. JCO Oncology Practice (2023)

Ryan J. HuttenChristopher R. WeilAndy J. KingBrandon BarneyCarma L. BylundAngela FagerlinDavid K. GaffneyDavid GillLaura SchererGita SunejaJonathan D. TwardEcho L. WarnerTheresa L. WernerGary WhippleJaden EvansSkyler B. Johnson

oncologytrustmulti-institutional analysiscomplementary medicineinformation sourcescancer patient exposurealternative medicinehealth sciences

33 Uplift (Engot-Ov67/Gog-3048) a Pivotal Cohort of Upifitamab Rilsodotin (Xmt-1536; Upri), a Napi2B-Directed Antibody Drug Conjugate (Adc) in Platinum-Resistant Ovarian Cancer. Gynecologic Oncology Reports (2022)

Debra RichardsonJill H. TsengTheresa L. WernerErika HamiltonJohn HaysLinda R. DuskaDeborah DoroshowRebecca C. ArendDavid StarksMarilyn HuangKyriakos PapadopoulosLeslie DeMarsEmily PutiriJamie BarrettBhavana Pothuri

pharmacologycervical canceroncologycancer researchmedical mycologycancer carecancer treatmentdrug discoverypharmacotherapyhepatologyprospective cohort studiesmolecular cancerimmunologymedicinal researchclinical mycologyretrospective cohort studiesdrug targetinghealth sciencespivotal cohort

Abstract Ot2-19-07: A Phase I/Ib Trial of the Cdk4/6 Antagonist Ribociclib (Rib) and the Hdac Inhibitor Belinostat (Bel) in Patients With Metastatic Triple Negative Breast Cancer and Recurrent Ovarian Cancer With Response Prediction by Genomics (Charge). Cancer Research (2022)

Shashank SamaKristen KelleyChristos VaklavasAndrea BildKenneth BoucherJohn LambJulia LehmanPhilip MoosTheresa WernerAdam Cohen

cancer biologydrug resistancepharmacologycancer researchoncologyhdac inhibitor belinostatcancer carecancer treatmentanti-cancer agentshost factorsovarian cancerrecurrent ovarian cancercell researchradiologymedicinal researchcancer imagingcancer managementenzyme inhibitionclinical researchhealth sciences

Berenice Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in Her2-Positive Early Breast Cancer. Cancers (2022)

Chau DangMichael S. EwerSuzette DelalogeJean-Marc FerreroRamon ColomerLuis de la Cruz-MerinoTheresa L. WernerKatherine DadswellMark VerrillDaniel EigerSriparna SarkarSanne Lysbet de HaasEleonora RestucciaSandra M. Swain

gynecologycancer biologybreast oncologypharmacologymetastasiscardiac safety studytumor biologyberenice final analysisoncologycancer researchadjuvant pertuzumabcancer carecancer riskcancer discoverydisease progressionradiation oncologyneoadjuvant pertuzumabbreast cancermedicinal researchgynecologic oncologysurgical oncologycancer growth

Complementary and Alternative Medicine Exposure in Oncology (Cameo) Study: A Multi-Institutional Cross-Sectional Analysis of Patients Receiving Cancer Treatment.. Journal of Clinical Oncology (2022)

Ryan J. HuttenChristopher R. WeilBrandon M. BarneyAngela FagerlinDavid K. GaffneyDavid Michael GillGary WhippleTerence Duane RhodesLaura SchererGita SunejaJonathan David TwardTheresa Louise WernerJaden EvansSkyler B Johnson

oncologyradiation oncologycomplementary medicinemulti-institutional cross-sectional analysiscancer treatmentalternative medicine

1
2
3
4
5
9
10 / page

Theresa Werner

University of Utah

Affiliations

School of Medicine

Department of Internal Medicine

Department of Obstetrics and Gynecology

Division of Gynecologic Oncology

Department of Internal Medicine

Division of Oncology

NoneTheresa Werner is currently serving as a Internal Medicine faculty at University of Utah.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Theresa Werner

University of Utah

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Durable Response to Braf Inhibitor Monotherapy in Recurrent Metastatic Low Grade Serous Ovarian Cancer. Gynecologic Oncology Reports (2024)

Shashank SamaSterling RosqvistTalicia SavageLesley LomoKiera SibbaldAlli StraubharTheresa L. Werner

gynecologymetastasisgynecologic cancersoncologycancer researchdurable responseovarian cancercancer treatmentinhibitor monotherapygynecologic oncology

Nccn Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024. Journal of the National Comprehensive Cancer Network (2024)

Phase 1/2A Study of Rivoceranib, a Selective Vegfr-2 Angiogenesis Inhibitor, in Patients With Advanced Solid Tumors. Cancer Research and Treatment (2024)

Yoon-Koo KangMin-Hee RyuYong Sang HongChang-Min ChoiTae Won KimBaek-Yeol RyooJeong Eun KimJohn R WeisRachel KingsfordCheol Hee ParkSeong JangArlo McGinnTheresa L WernerSunil Sharma

cancer researchangiogenesispharmacologycancer treatmentclinical researchadvanced solid tumors

Sitravatinib in Patients With Solid Tumors Selected by Molecular Alterations: Results From a Phase Ib Study. Future Oncology (2024)

Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative Medicine. JCO Oncology Practice (2023)

oncologytrustmulti-institutional analysiscomplementary medicineinformation sourcescancer patient exposurealternative medicinehealth sciences

Shashank SamaKristen KelleyChristos VaklavasAndrea BildKenneth BoucherJohn LambJulia LehmanPhilip MoosTheresa WernerAdam Cohen

oncologyradiation oncologycomplementary medicinemulti-institutional cross-sectional analysiscancer treatmentalternative medicine

1
2
3
4
5
9
10 / page

Similar Faculty Members

Roger B. Cohen

Institution

University of Pennsylvania

oncology

radiation oncology

Afshin Dowlati

Institution

Case Western Reserve University

cancer letter

bronchial neoplasm

Elisabeth Heath

Institution

Wayne State University

translational research

prostate cancer research

Anthony Shields

Institution

Wayne State University

radiation oncology

gastrointestinal medical oncology

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Peter J. O'Dwyer

Institution

University of Pennsylvania

oncology

pharmacology

Heather Wakelee

Institution

Stanford University

radiation oncology

mesothelioma

Kenneth Boucher

Institution

University of Utah

cancer letter

biomedical data science

Scott Joseph Antonia

Institution

Duke University

oncology

cancer research

Krishnansu Tewari

Institution

University of California, Irvine

oncology

gynecologic oncology

Similar Faculty Members

Roger B. Cohen

Institution

University of Pennsylvania

oncology

radiation oncology

Afshin Dowlati

Institution

Case Western Reserve University

cancer letter

bronchial neoplasm

Elisabeth Heath

Institution

Wayne State University

translational research

prostate cancer research

Anthony Shields

Institution

Wayne State University

radiation oncology

gastrointestinal medical oncology

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Peter J. O'Dwyer

Institution

University of Pennsylvania

oncology

pharmacology

Heather Wakelee

Institution

Stanford University

radiation oncology

mesothelioma

Kenneth Boucher

Institution

University of Utah

cancer letter

biomedical data science

Scott Joseph Antonia

Institution

Duke University

oncology

cancer research

Krishnansu Tewari

Institution

University of California, Irvine

oncology

gynecologic oncology